Mavelertinib Uses, Dosage, Side Effects and more
Mavelertinib is under investigation in clinical trial NCT02349633 (Study for Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)).
| Trade Name | Mavelertinib |
| Generic | Mavelertinib |
| Mavelertinib Other Names | Egfr t790m inhibitor pf-06747775, Mavelertinib |
| Type | |
| Formula | C18H22FN9O2 |
| Weight | Average: 415.433 Monoisotopic: 415.188049147 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
